Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 353 - 360 of 12013 results
EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them?
January 16, 2025| Blog| Viewpoint
EnforceMintz — Healing Healthcare? DOJ’s Cybersecurity Enforcement Trained Up for 2025
January 16, 2025| Blog| Viewpoint
Deadline Approaching for Massachusetts Pay Data Reporting
January 15, 2025| Blog| Viewpoint
Clouds Gather over ESG Investing as US Banks and Asset Managers Desert Climate Coalitions
January 15, 2025| News
Amazon Sr. Counsel Moves to Mintz's Tech, Telecom Practice
January 15, 2025| News
FTC Announces 2025 Thresholds for HSR Act Filings and Interlocking Directorates Violations
January 14, 2025| Alert| Viewpoint
Legal Tech's Predictions for Emerging Technology in 2025
January 13, 2025| News
FTC Blog Outlines Factors for Companies to Consider About AI — AI: The Washington Report
January 10, 2025| Article| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|